Stroke (CVA) or TIANCT07358169
Mirror Therapy on Motor Recovery and Pain of Hemiparetic Arm
A study testing technique in people with Stroke (CVA) or TIA and Hemiparesis, run by Mansoura University at 1 site in Egypt.
Trial summary
evaluate the effect of mirror therapy on motor recovery and pain of hemiparetic arm post stroke Read more about this study
- Who is it for?
- Ages 20 to 60 years
- Conditions the study is for
- Stroke (CVA) or TIA, Hemiparesis
- What is being tested?
- technique
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 72 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Nov 2025to Apr 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- First stroke attack (ischemic and haemorrhagic )
- Unilateral stroke with hemiparesis
- Able to understand simple verbal language
Who cannot join
- Severe cognitive impairments.
- Orthopedic or rheumatologic problems restricting upper extremity motor function.
- Contraindications to mirror therapy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Impact of Mirror Therapy on Motor Recovery and Pain of Hemiparetic Arm Post Stroke: A Randomized Controlled Trial
evaluate the effect of mirror therapy on motor recovery and pain of hemiparetic arm post stroke
- Conditions
- Stroke (CVA) or TIA, Hemiparesis
- Being tested
- technique, Control
- Medical subject headings
- Stroke, Paresis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
techniqueOther
the participant performs arm exercise behind mirror
ControlOther
the control group receive usual hospital care
| Study group | Role | What they receive |
|---|---|---|
| control | Other | usual hospitl care Receives: Other: Control |
| mirror group | Experimental | Not described Receives: Other: technique; Other: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Motor Function Assessment
measured by Fugl-Meyer Assessment for upper limb motor function. to describe impairment severity, quantify motor recovery, guide treatment planning, and evaluate outcomes. The scale comprises five domains with a maximum total score of 226 points (Motor 100; Sensation 24; Balance 14; Joint ROM 44; Joint Pain 44).
Scoring is based on direct observation of performance. Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible scale score is 226.
Points are divided among the domains as follows:
Motor score: ranges from 0 (hemiplegia) to 100 points (normal motor performance). Divided into 66 points for upper extremity and 34 points for the lower extremity.
Sensation: ranges from 0 to 24 points. Divided into 8 points for light touch and 16 points for position sense.
Balance: ranges from 0 to 14 points. Divided into 6 points for sitting and 8 points for standing.
Measured: 3 weeks
Secondary outcomes (2)
Functional independence
Functional independence (measured by Modified Rankin Scale). it is a 7-point scale (0-6) that measures disability after a stroke or neurological event, assessing the ability to perform daily activities, from no disability (0) to death (6).
The Modified Rankin Scale Grade mRS 0 No symptoms at all
- No significant disability: despite symptoms, able to carry out all usual duties and activities
- Slight disability: unable to perform all previous activities but able to look after own affairs without assistance
- Moderate disability: requiring some help but able to walk without assistance
- Moderately severe disability: unable to walk without assistance and attend to own bodily needs without assistance
- Severe disability: bedridden, incontinence, and requiring constant nursing care and attention
- Death
Measured: 3 weeks
Pain assessment
Pain assessment (measured by Numeric Pain Rating Scale.) it is a 11-point scale (0-10) where patients rate their pain intensity, with 0 meaning no pain and 10 representing the worst imaginable pain.
scoring system 0: No Pain 1-3: Mild Pain 4-6: Moderate Pain 7-10: Severe Pain
Measured: 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jan 2026
- Study start15 Nov 2025
- Primary completion15 Feb 2026
- Study completionApr 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stroke (CVA) or TIAStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 72 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mansoura University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Heba Abubakr Mohamed Salama, Mansoura University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07358169
- Sponsor's protocol ID
- Mirror therapy
- Status last verified
- Mar 2026
- First submitted
- 4 Jan 2026
- Last updated
- 17 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No